STAT+: U.S. Supreme Court gives Amgen a boost by agreeing to review a closely watched patent case
In a boost for Amgen, the U.S. Supreme Court on Friday agreed to hear a…
Category: Pharma
STAT+: A ‘blank check’: Bill to boost antibiotic development blasted as a ‘flawed’ giveaway to pharma
Amid mounting concern over antibiotic resistance, a coalition of academics and advocacy groups is urging…
STAT+: Pharmalittle: Europe approves a Sanofi and AstraZeneca RSV shot; CDC updates opioid prescribing guidelines
And so, another working week will soon draw to a close. Not a moment too…
STAT+: A leaked version of a U.K.-India free trade deal sparks alarm over access to medicines
A leaked draft version of a trade agreement being negotiated between the United Kingdom and…
STAT+: Pharmalittle: Moderna must face patent claims over its Covid-19 vaccine; Pfizer and BioNTech testing combo Covid and flu shot
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: FDA panel urges improved regulation of pulse oximeters; CVS Health agrees to $5 billion settlement over opioid lawsuits
Good morning from San Diego. I’m Jonathan Wosen, STAT’s West Coast biotech reporter, and I’m…
.jpg)
STAT+: Pharmalittle: Pfizer maternal RSV vaccine meets pivotal study’s goal; Lilly cuts its annual profit forecast
Tumble out of bed and stumble to the kitchen, pour myself a cup of ambition,…
Opinion: Biopharma innovation needs to harness lessons learned from Covid-19
The pandemic is a prime case study of what can be accomplished when science delivers….
STAT+: Pharmalittle: FDA advisers vote down pediatric brain cancer drug; AbbVie drops out of psoriasis partnership
Good morning, and welcome to a spooky edition of Pharmalittle. It’s Jason Mast here, filling…
STAT+: Pharmalittle: Drugmaker raises price of old chemo med 10-fold amid shortages; Alnylam cites drug-price law in halting trial
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Drugmaker raises the price of an old chemo medicine tenfold amid persistent shortages
Amid sporadic shortages of a drug that is essential in preparing patients for lifesaving, cancer-fighting…
STAT+: Pharmalittle: Italy probes Pfizer over profit transfers; FDA postpones meeting for OTC birth control pill
Rise and shine, another busy day is on the way. However, this is also shaping…
STAT+: Pharmalittle: White House pharma help in plan to combat hepatitis C; J&J blood cancer drug will cost $39,500 a month
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Q&A: A health justice lawyer and new MacArthur ‘genius’ on pharma’s patent games
Priti Krishtel has had it with the patent tricks up pharma’s sleeves. The co-executive director…
STAT+: Merck fined $39 million by Spain’s antitrust regulator for ‘serious’ violation
The antitrust regulator in Spain has fined Merck approximately $39 million for preventing a competitor…
STAT+: Pharmalittle: Online prescribing prompts scrutiny and concern; FDA is pushed to approve OTC birth control pills
Top of the morning to you. Gray skies are hovering once again over the Pharmalot…
STAT+: Pharmalittle: Merck suddenly finds Ebola vaccine doses in its freezers; drugs studied to combat women’s midlife mood swings
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Pfizer plans to quadruple price of its Covid-19 vaccine; pharma pushed to tie exec compensation to access to meds
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Dozens of institutional investors urge drugmakers to link executive compensation to access to medicines
Three dozen institutional investors are urging the boards at several of the world’s largest pharmaceutical…
STAT+: Novartis agrees to license a best-selling cancer drug to dozens of low- and middle-income countries
Amid a push to widen access to medicines to poor countries, Novartis has reached an…
STAT+: How one pharma insider sees the drug pricing reform law: the impact will ‘vary by product and by company’
After years of stops and starts, a law was finally passed in Congress this summer…
STAT+: Pharmalittle: Pharma tries to blunt Medicare power to negotiate prices; FDA panel supports withdrawal of premature birth drug
Top of the morning to you. Another deliciously shiny day is unfolding over the Pharmalot…
Opinion: What the Makena vote means about accelerated approval, trust, and the FDA
On Wednesday, the FDA advisory committee that oversees obstetrics, reproductive, and urologic drugs voted 14-1…
STAT+: FDA panel votes that a controversial premature birth medication should be withdrawn
After an extraordinary three-day hearing, an expert panel of advisers to the U.S. Food and…
STAT+: Pharmalittle: Merck KGaA probed by French court for misleading info; former Genentech scientists given prison terms over trade-secret theft
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: How many? A new analysis finds 1.3 million American adults rationed insulin due to cost
Amid ongoing controversy over the cost of insulin, a new analysis finds that approximately 1.3…
STAT+: Pharmalittle: J&J will cut its workforce; pharma gave Dems money despite threats over Medicare drug-price negotiation
Top of the morning to you. Another busy day is unfolding on the Pharmalot satellite…
STAT+: Pharmalittle: BioNTech eyes cancer vaccine before decade’s end; Pfizer asks Supreme Court to review copay programs
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Josh Bilenker’s last biotech sold for $8 billion. His next one is cloaked in mystery but loaded with money
Josh Bilenker’s last company, Loxo Oncology, was purchased by Eli Lilly for $8 billion. No…
STAT+: Milestone Pharma’s nasal spray rapidly restores normal heart rhythm, achieving goal of key study
Milestone Pharmaceuticals said Monday that an experimental nasal-spray medicine acted quickly to treat people experiencing…
STAT+: What to know about Roche’s experimental Alzheimer’s treatment
The next big Alzheimer’s disease study readout is almost here. Roche is nearing the completion…
STAT+: European Prosecutor’s Office confirms it’s investigating European Union Covid vaccine contracts
In an unusual step, the European Public Prosecutor’s Office (EPPO) confirmed it has opened an…
STAT+: Lawmakers push NIH to disclose steps being taken to ensure clinical trial results are reported
A group of Republican senators is demanding to know what steps the U.S. National Institutes…
STAT+: Pharmalittle: Biden to sign executive order to push drug costs down; big grocers get bad grades for antibiotic policies
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Several big U.S. grocery chains are failing to stop antibiotic overuse in their meat supply chains
Amid rising concern over antibiotic resistance, a new report finds that a dozen of the…
STAT+: AstraZeneca is fined by South Korea for an anticompetitive deal over a cancer drug
South Korea’s anti-trust regulator has fined AstraZeneca and a local generic drugmaker a total of…
STAT+: Pharmalittle: GSK vaccine for RSV was effective in study of older adults; Eisai is confident of U.S. approval of its Alzheimer’s drug
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…
Opinion: Why the U.S. needs a public benefit biopharma industry
The biopharma industry is failing Americans, economically and medically. U.S. biotechnology and pharmaceutical companies, like…
STAT+: Alphabet’s AI predicted the structure of 200 million proteins. Can it really speed up drug discovery?
Every two years since 1994, scientists have come together for an experiment — better described…
STAT+: Merck pays $250 million to license a Moderna skin-cancer vaccine candidate
Merck on Wednesday agreed to extend an ongoing collaboration with Moderna to develop a personalized…
STAT+: FDA and large compound pharmacies settle a long-running dispute over a key list for ingredients
The U.S. Food and Drug Administration and a trade group that represents large compound pharmacies…
STAT+: Pharmalittle: Walmart joins rivals in entering clinical trial work; Maiden Pharma failed to do quality tests on cough syrups
Top of the morning to you, and a fine one it is. After all, there…
Virtual Event: Biosimilars’ Meteoric Moment
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: BIO CEO resigns amid board disagreements; Pfizer exec denies allegations over EU Covid-vaccine deal
Good morning, everyone, and how are you today? We are doing just fine thank you,…
STAT+: European Commission says preliminary findings indicate Teva violated antitrust rules
After three years of probing, the European Commission has reached a preliminary decision that Teva…
After tough period for lobby, BIO chief Michelle McMurry-Heath goes on leave
WASHINGTON — Michelle McMurry-Heath, one of the most prominent faces of the drug industry in Washington,…
STAT+: Merck’s Covid-19 pill was no better than placebo in lowering the risk of hospitalization
A Merck pill used to combat Covid-19 failed to demonstrate it can lower the risk…
STAT+: Pharmalittle: Medicare can still penalize drugmakers for hiking prices to privately insured patients; FDA explains push to withdraw premature-birth drug
And so, another working week will soon draw to a close. Not a moment too…
STAT+: FDA and Covis release dueling documents over the fate of a controversial drug for premature births
In the run-up to an extremely unusual hearing later this month, newly released documents underscore…
STAT+: Pharmalittle: Vertex exec says prices for gene therapies are ‘in the ballpark’; insulin access in poor countries remains spotty
Rise and shine, everyone, another busy day is on the way. And this is especially…